In addition, one of its ligands, PD-L1, can be expressed on a wide range of cell types, including T cells, epithelial cells, endothelial cells, and tumor cells after exposure to the cytokine interferon-gamma (IFN-γ) produced by activated T cells (118). This evidence concerns the gene IFNG and neoplasm.